Literature DB >> 11280639

The value of capillary whole blood lactate for blood transfusion requirements in anaemia of prematurity.

B Frey1, M Losa.   

Abstract

OBJECTIVE: To evaluate the usefulness of blood lactate as an indication for blood transfusion in anaemia of prematurity by means of a study protocol which considers the site of blood sampling and the repeatability of lactate measurements.
DESIGN: Prospective clinical study.
SETTING: Multidisciplinary, neonatalpaediatric intensive care unit of a non-university, teaching children's hospital. PATIENTS AND METHODS: Comparison of pre- and 48-h post-transfusion capillary whole blood lactate in 18 anaemic premature babies. In 30 neonates the agreement between capillary and arterial lactate was analysed by using the Bland Altman plot. In 30 stable premature infants four capillary lactate measurements were carried out within 24 h and analysed with regard to variability (coefficient of variation (CV); association between SD and mean) and to establish normal values.
RESULTS: In the transfused infants, haematocrit increased from 23 (SD 3)% to 37 (SD 3)%. Mean lactate decreased from 2.5 (SD 1.0) to 1.7 (SD 0.5) mmol/l (p = 0.003). Pretransfusion lactate did not correlate with pre-transfusion haematocrit, heart rate, respiratory rate, number of apnoeas/bradycardias and weight gain (multiple regression). The mean difference between capillary and arterial lactate was 0.17 (SD 0.24) mmol/l and the 95 % confidence interval (CI) was -0.31 to 0.65 mmol/l. The CV of repetitive measurements was 19.8 (SD 9.8)% and SD correlated positively with mean lactate values (p = 0.001); the 95 % CI (normal range for premature infants) was 1.56-1.90 mmol/l.
CONCLUSIONS: Capillary whole blood lactate measurements in newborn babies agree excellently with arterial values. Lactate measurements add little information to the decision whether to transfuse or not, considering the variability of this parameter in stable premature infants and the lack of correlation with other possible clinical indicators of compromised oxygen delivery.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11280639     DOI: 10.1007/s001340000712

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  8 in total

Review 1.  Safe paediatric intensive care. Part 2: workplace organisation, critical incident monitoring and guidelines.

Authors:  Bernhard Frey; Andrew Argent
Journal:  Intensive Care Med       Date:  2004-04-30       Impact factor: 17.440

Review 2.  Neonatal transfusion practice.

Authors:  N A Murray; I A G Roberts
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-03       Impact factor: 5.747

3.  Functional echocardiographic assessment of myocardial performance in anemic premature infants: a pilot study.

Authors:  Maurizio Radicioni; Stefania Troiani; Daniele Mezzetti
Journal:  Pediatr Cardiol       Date:  2012-01-25       Impact factor: 1.655

4.  Neonatal red blood cell transfusions: searching for better guidelines.

Authors:  Kavita Kasat; Karen D Hendricks-Muñoz; Pradeep V Mally
Journal:  Blood Transfus       Date:  2011-01       Impact factor: 3.443

Review 5.  Safe paediatric intensive care. Part 1: Does more medical care lead to improved outcome?

Authors:  Bernhard Frey; Andrew Argent
Journal:  Intensive Care Med       Date:  2004-04-22       Impact factor: 17.440

6.  The relationship between blood lactate concentration, the Paediatric Index of Mortality 2 (PIM2) and mortality in paediatric intensive care.

Authors:  Kevin P Morris; Phil McShane; John Stickley; Roger C Parslow
Journal:  Intensive Care Med       Date:  2012-10-26       Impact factor: 17.440

Review 7.  When to transfuse preterm babies.

Authors:  E F Bell
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2008-07-24       Impact factor: 5.747

8.  Agreement between capillary and venous lactate in emergency department patients: prospective observational study.

Authors:  Colin A Graham; Ling Yan Leung; Ronson Sl Lo; Kwok Hung Lee; Chun Yu Yeung; Suet Yi Chan; Giles N Cattermole; Kevin Kc Hung
Journal:  BMJ Open       Date:  2019-04-03       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.